Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for IDEXX Laboratories, Inc. (IDXX : NSDQ)
 
 • Company Description   
IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk.

Number of Employees: 10,350

 
 • Price / Volume Information   
Yesterday's Closing Price: $366.36 Daily Weekly Monthly
20 Day Moving Average: 914,390 shares
Shares Outstanding: 84.01 (millions)
Market Capitalization: $30,776.89 (millions)
Beta: 1.10
52 Week High: $706.95
52 Week Low: $330.66
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -26.85% -20.17%
12 Week -25.02% -21.07%
Year To Date -44.36% -35.14%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
ONE IDEXX DRIVE
-
WESTBROOK,ME 04092
USA
ph: 207-556-0300
fax: 207-556-4346
investorrelations@idexx.com http://www.idexx.com
 
 • General Corporate Information   
Officers
Jonathan J. Mazelsky - Chief Executive Officer and President
Lawrence D. Kingsley - Non-Executive Board Chair
Brian P. McKeon - Chief Financial Officer and Executive Vice Preside
Jonathan W. Ayers - Director
Bruce L. Claflin - Director

Peer Information
IDEXX Laboratories, Inc. (ABMD)
IDEXX Laboratories, Inc. (DMDS)
IDEXX Laboratories, Inc. (CPWY.)
IDEXX Laboratories, Inc. (EQUR)
IDEXX Laboratories, Inc. (ECIA)
IDEXX Laboratories, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 45168D104
SIC: 2835
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 07/29/22
Share - Related Items
Shares Outstanding: 84.01
Most Recent Split Date: 6.00 (2.00:1)
Beta: 1.10
Market Capitalization: $30,776.89 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $1.55 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $8.24 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 19.05% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/29/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 44.47
Trailing 12 Months: 42.95
PEG Ratio: 2.33
Price Ratios
Price/Book: 48.10
Price/Cash Flow: 36.57
Price / Sales: 9.40
EPS Growth
vs. Year Ago Period: -3.40%
vs. Previous Quarter: 20.11%
Sales Growth
vs. Year Ago Period: 7.57%
vs. Previous Quarter: 4.43%
ROE
03/31/22 - 103.70
12/31/21 - 102.84
09/30/21 - 106.60
ROA
03/31/22 - 29.90
12/31/21 - 31.16
09/30/21 - 32.14
Current Ratio
03/31/22 - 1.12
12/31/21 - 1.25
09/30/21 - 1.48
Quick Ratio
03/31/22 - 0.81
12/31/21 - 0.90
09/30/21 - 1.07
Operating Margin
03/31/22 - 22.43
12/31/21 - 23.17
09/30/21 - 24.14
Net Margin
03/31/22 - 22.43
12/31/21 - 23.17
09/30/21 - 24.14
Pre-Tax Margin
03/31/22 - 27.61
12/31/21 - 28.07
09/30/21 - 28.33
Book Value
03/31/22 - 7.62
12/31/21 - 8.14
09/30/21 - 8.91
Inventory Turnover
03/31/22 - 5.07
12/31/21 - 5.33
09/30/21 - 5.53
Debt-to-Equity
03/31/22 - 1.21
12/31/21 - 1.12
09/30/21 - 1.03
Debt-to-Capital
03/31/22 - 54.73
12/31/21 - 52.91
09/30/21 - 50.74
 

Powered by Zacks Investment Research ©